NVIC_ID,compound_image,Inhibitor_name,Smiles,Pubchem_id,Drug_bank_id,Chemspider_id,Target,Assay_type,Assay_description,Assay_source,Cell_type,IC50_(nM),EC50_(nM),Outcome,MW_(g/mol),HBA,HBD,RB,LogP,TPSA,Pubmed_id,Reference,Curator_email_id
NVIC0001,,OSU-03012,C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F,10027278,NULL,8202849,PDK-1,Reporter assay,Non-linear regression analysis,"Selleck Chemicals (Houston, TX, USA)",HEK 293T cells,0,400,Replication inhibited in NiV-Luc,460.46,4,2,4,5.76,72.94,25986249,https://www.sciencedirect.com/science/article/pii/S0166354215001126?via%3Dihub,kanikatuteja@gmail.com
NVIC0002,,Cepharanthine,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,10206,DB16824,9791,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,606.72,8,0,2,6.87,61.86,36808582,https://pubmed.ncbi.nlm.nih.gov/36808582/,bhupender.thakur855@gmail.com
NVIC0003,,Comp11163,CC(=C)C1CC2=C(O1)C=CC3=C2NC(=O)C34CC56C(C4(C)C)CC7(CCCN7C5=O)C(=O)N6,102224080,NULL,NULL,RNA-dependent RNA polymerase (RdRp),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of RNA-dependent RNA polymerase (RdRp),447.54,4,2,1,2.44,87.74,36907056,https://pubmed.ncbi.nlm.nih.gov/36907056/,bhupender.thakur855@gmail.com
NVIC0004,,"1-acetyl-17-[3-(trifluoromethyl)phenyl]-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaene-16,18-dione",CC(=O)C12C3C(C(C4=CC=CC=C41)C5=CC=CC=C25)C(=O)N(C3=O)C6=CC=CC(=C6)C(F)(F)F,1037027,NULL,891395,attachment glycoprotein (Niv-G),"virtual screening, molecular docking and ADMET prediction",ADME/Tox filter server,ZINC database,NULL,0,0,Inhibit the NiV-G,461.44,3,0,2,4.85,54.45,NULL,https://www.omicsonline.org/open-access/virtual-screening-for-identification-of-small-lead-compound-inhibitors-ofnipah-virus-attachment-glycoprotein-2153-0645-1000180.pdf,nishisharmacool14@gmail.com
NVIC0005,,G3,O=C(CSC1=NN=NN1C1=CC=CC2=C1C=CC=C2)N1CCCC2=C1C=CC=C2,1042364,NULL,894998,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,401.5,6,0,4,3.89,63.91,33450550,https://pubmed.ncbi.nlm.nih.gov/33450550/,bhupender.thakur855@gmail.com
NVIC0006,,U73122,CC12CCC3C(C1CCC2NCCCCCCN4C(=O)C=CC4=O)CCC5=C3C=CC(=C5)OC,104794,NULL,94596,Inhibits PLC mediated pathways,HTS immunolabeling assay,Non-linear regression analysis,"Sigma Chemical Company (St. Louis, MO, USA).",Vero cells,36320,0,Inhibition of viral replication,464.65,4,1,9,4.99,58.64,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0007,,Comp4641,CC(C)CC1C(=O)N2C(N1)C3(CC4C(=O)NC(O3)(C5=NC6=CC=CC=C6C(=O)N45)C)C7=CC=CC=C72,10552917,NULL,8728308,RNA-dependent RNA polymerase (RdRp),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of RNA-dependent RNA polymerase (RdRp),485.54,7,2,2,2.25,105.56,36907056,https://pubmed.ncbi.nlm.nih.gov/36907056/,bhupender.thakur855@gmail.com
NVIC0008,,7-chloro-3-(2-methoxyphenyl)-2(1H)-quinolone,COC1=CC=CC=C1C2=CC3=C(C=C(C=C3)Cl)NC2=O,10613168,NULL,NULL,Ephrin-B2,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Ephrin-B2 chain,285.73,2,1,2,3.86,42.09,37442011,https://pubmed.ncbi.nlm.nih.gov/37442011/,bhupender.thakur855@gmail.com
NVIC0009,,Benzamil,C1=CC=C(C=C1)CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N,108107,NULL,97202,Inhibitor of sodium/hydrogen transporter,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,65040,0,Sodium channel blockage,319.76,6,4,3,0.54,145.3,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0010,,Ryanodine,CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1O)O4)O)O)OC(=O)C6=CC=CN6)(C(C)C)O)C)O)C)O,11317883,NULL,16736002,Stimulates calcium release from the ER via ryanodine receptors.,HTS immunolabeling assay,Non-linear regression analysis,"Merck Scientific (Kilsyth, VIC Australia)",Vero cells,65710,0,Inhibition of henipavirus replication,493.55,9,7,3,-0.19,172.7,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0011,,Tanshinone I,CC1=C2C=CC3=C(C2=CC=C1)C(=O)C(=O)C4=C3OC=C4C,114917,NULL,NULL,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of NiV surface glycoprotein,276.29,3,0,0,4.1,47.28,38048723,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746367/,bhupender.thakur855@gmail.com
NVIC0012,,Gentianose,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3(C(C(C(O3)CO)O)O)CO)O)O)O)O)O)O)O,117678,NULL,105162,Non-Structural Protein - C,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Non-Structural Protein - C,504.44,16,11,8,-7.57,268.68,37222609,https://pubmed.ncbi.nlm.nih.gov/37222609/,bhupender.thakur855@gmail.com
NVIC0013,,KIN1408,COC1=CC2=C(C=C1)SC(=N2)NC(C3=CC=C(C=C3)OC(F)F)C4=C(C5=C(C=CC=N5)C=C4)O,119081414,NULL,57251290,Activation of IRF3-dependent innate immune responses,CPE visual,Two-way analysis of variance with Bonferroni posttests,"Life Chemicals Inc. and Kineta, Inc.",Vero E6 cells,0,0,Decrease in the number of infectious virus particles,479.51,7,2,7,6.36,76.5,26676770,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810700/,kanikatuteja@gmail.com
NVIC0014,,A23187,CC1CCC2(C(CC(C(O2)C(C)C(=O)C3=CC=CN3)C)C)OC1CC4=NC5=C(O4)C=CC(=C5C(=O)O)NC,11957499,NULL,10131749,Calcium ionophore,HTS immunolabeling assay,Non-linear regression analysis,"Sigma Chemical Company (St. Louis, MO, USA)",Vero cells,70,0,Inhibition of henipavirus replication,523.63,7,3,7,5.53,126.68,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0015,,GS-5734,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,121304016,DB14761,58827832,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,"GS-5734 were synthesized at Gilead Sciences, Inc.",HeLa and HEK293T/17 cells,0,45,Inhibition of transcription in NiV (Rec. M-Luc2AM),602.59,13,4,13,2.31,203.55,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,anshu@imtech.res.in
NVIC0015,,GS-5734,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,121304016,DB14761,58827832,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,"GS-5734 were synthesized at Gilead Sciences, Inc.",HeLa and HEK293T/17 cells,0,29,Inhibition of transcription in NiV (Rec. M-GFP2AM),602.59,13,4,13,2.31,203.55,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,priyankapaul008@gmail.com
NVIC0015,,GS-5734,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,121304016,DB14761,58827832,RNA-dependent RNA polymerase (RdRp),Cytotoxicity kit,Non-linear regression analysis,"GS-5734 were synthesized at Gilead Sciences, Inc.",HeLa cells,0,47,Inhibition of replication in NiV (M-1999),602.59,13,4,13,2.31,203.55,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,priyankapaul008@gmail.com
NVIC0015,,GS-5734,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,121304016,DB14761,58827832,RNA-dependent RNA polymerase (RdRp),Cytotoxicity kit,Non-linear regression analysis,"GS-5734 were synthesized at Gilead Sciences, Inc.",HeLa and H358 cells,0,32,Inhibition of replication in NiV (B-2004) or Inhibition of virus-induced CPE,602.59,13,4,13,2.31,203.55,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,priyankapaul008@gmail.com
NVIC0016,,Brilliant Green,CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=CC=CC=C3,12450,DB11279,11942,Calcium modulation,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,218,0,Inhibition of NiV infection.,385.58,1,0,7,5.95,6.25,19889218,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781006/,kanikatuteja@gmail.com
NVIC0017,,Pyrazofurin,C(C1C(C(C(O1)C2=NNC(=C2O)C(=O)N)O)O)O,135413551,NULL,10570780,Orotidine 5?-monophosphate decarboxylase,Reporter assay,NULL,Toronto Research Chemicals,HEK 293T cells,0,432,Inhibition cellular of Pyrimidine biosynthesis,259.22,7,6,3,-2.63,161.92,24680955,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100748/,kanikatuteja@gmail.com
NVIC0017,,Pyrazofurin,C(C1C(C(C(O1)C2=NNC(=C2O)C(=O)N)O)O)O,135413551,NULL,10570780,Orotidine 5?-monophosphate decarboxylase,Reporter assay,NULL,Toronto Research Chemicals,HEK 293T cells,0,281,Inhibition cellular of Pyrimidine biosynthesis,259.22,7,6,3,-2.63,161.92,24680955,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100748/,kanikatuteja@gmail.com
NVIC0017,,Pyrazofurin,C(C1C(C(C(O1)C2=NNC(=C2O)C(=O)N)O)O)O,135413551,NULL,10570780,Replication,CPE visual,NULL,NULL,Vero E6 cells,0,0,Inhibit replication,259.22,7,6,3,-2.63,161.92,16641448,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472238/,kanikatuteja@gmail.com
NVIC0018,,Tetrahydrofolic acid,C1C(NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,135444742,DB00116,82572,"Aldehyde dehydrogenase 1 family, member l2",NULL,NULL,NULL,NULL,0,0,NULL,445.44,9,8,9,-0.28,211.56,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0019,,3229-0951,OC1=CC=C(\C=N\NC2=NC(NC3=CC=CC=C3)=NC(=N2)N2CCOCC2)C=C1,136774454,NULL,11683895,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,391.44,9,3,6,2.6,107.79,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0020,,1593-0009,COC1=C(C=CC(=C1)C=NNC2=CC(=NC(=N2)N3CCOCC3)N4CCOCC4)O,136919850,NULL,17741464,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,414.47,10,2,6,1.31,104.57,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0021,,9290-0114,COC1=C(C=C(C=C1)C=C2C(=O)NC(=N)S2)O,137836152,NULL,4689986,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,250.28,5,3,2,1.54,82.41,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0022,,Comp12696,CC1C(=O)N2C(N1)C3(CC4C(O3)(C(C(=O)C5=NC6=CC=CC=C6C(=O)N45)(C)C)O)C7=CC=CC=C72,139591088,NULL,62285717,RNA-dependent RNA polymerase (RdRp),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of RNA-dependent RNA polymerase (RdRp),472.5,8,2,0,1.83,113.76,36907056,https://pubmed.ncbi.nlm.nih.gov/36907056/,bhupender.thakur855@gmail.com
NVIC0023,,Comp11265,CC1(C=CC2=CC3=C(C=C2O1)NC(=O)C34CC56C(C4(C)C)CC7(CCCN7C5=O)C(=O)N6)C,139591449,NULL,NULL,RNA-dependent RNA polymerase (RdRp),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of RNA-dependent RNA polymerase (RdRp),447.54,4,2,0,2.74,87.74,36907056,https://pubmed.ncbi.nlm.nih.gov/36907056/,bhupender.thakur855@gmail.com
NVIC0024,,"3-(beta-D-Glucopyranosyloxy)-8-(beta-D-glucopyranuronosyloxy)-3',4',5,7-tetrahydroxyflavone",C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3O)O)OC4C(C(C(C(O4)C(=O)O)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O,14887603,NULL,NULL,Non-Structural Protein - C,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Non-Structural Protein - C,656.5,18,12,7,-3.27,326.96,37222609,https://pubmed.ncbi.nlm.nih.gov/37222609/,bhupender.thakur855@gmail.com
NVIC0025,,ZHAWOC21026,CN(C(=O)COC1=CC=CC2=C1OC(C)(C)C2)C1=NC2=C(CCCC2)S1,152138821,NULL,NULL,RNA-dependent RNA polymerase (RdRp),RealTime-Glo MT cell viability assay,virus inhibition assay,NULL,"rNiV-EGFP, PGSA745-EFNB2 cells",80,0,inhibition of RdRp,372.49,5,0,4,3.78,51.66,34724816,https://pubmed.ncbi.nlm.nih.gov/34724816/,bhupender.thakur855@gmail.com
NVIC0026,,FD012,OC(=O)C1=C(Cl)C=CC(=C1)C1=CC=C(O1)\C=C1/SC(=S)N(CCC2=CC=C(OCC3CC3)C=C2)C1=O,155669302,NULL,NULL,class I viral fusion protein,"Cytotoxicity, pseudo virus infection inhibition",Luciferase activity,American Type Culture Collection (ATCC),U87,70,0,inhibition of class I viral fusion protein,540.06,6,1,9,6.53,79.98,35336896,https://pubmed.ncbi.nlm.nih.gov/35336896/,bhupender.thakur855@gmail.com
NVIC0027,,Comp10694,CC1CC23CC4C(C5(CC4(C[N+]2(C1)[O-])N(C3=O)C)C6=C(C7=C(C=C6)OC(CC7=O)(C)C)NC5=O)(C)C,156583043,NULL,32675150,RNA-dependent RNA polymerase (RdRp),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of RNA-dependent RNA polymerase (RdRp),493.6,5,1,0,3.37,98.77,36907056,https://pubmed.ncbi.nlm.nih.gov/36907056/,bhupender.thakur855@gmail.com
NVIC0028,,Lactitol,OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,157355,DB12942,138481,matrix protein (NiV-M),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of matrix protein (NiV-M),344.31,11,9,8,-5.76,200.53,38355980,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866979/,bhupender.thakur855@gmail.com
NVIC0029,,2-APB(2-Aminoethyl Diphenylborinate),B(C1=CC=CC=C1)(C2=CC=CC=C2)OCCN,1598,NULL,1540,Inhibitor of IP3 mediated calcium release from the ER,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,133310,0,Inhibition of henipavirus replication,225.1,2,1,5,0.77,35.25,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0030,,Rosmariquinone,CC(C)C1=CC2=C(C3=C(C=C2)C(CCC3)(C)C)C(=O)C1=O,160142,NULL,NULL,RNA-dependent RNA polymerase (RdRp),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of RdRp,282.38,2,0,1,4.11,34.14,38048723,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746367/,bhupender.thakur855@gmail.com
NVIC0031,,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,16231,NULL,15403,Inhibitor of sodium channels,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,656470,0,Sodium channel blockage,229.63,5,4,1,-1.29,159.29,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0032,,"CA1001[(-)-(r,r)-N,N?-bis[11-(ethoxycarbonyl)undecyl]-n,n?-4,5-tetramethyl-3,6-dioxaoctanediamide]",CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC,163688476,NULL,2343275,Calcium ionophore,HTS immunolabeling assay,Non-linear regression analysis,"Merck Scientific (Kilsyth, VIC Australia)",Vero cells,348990,0,Inhibition of henipavirus replication,394.51,5,1,10,3.86,77.1,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0033,,1611-4804,CCOC(=O)C1=C(N=c2n(c(=O)/c(=C\c3cc(ccc3OC(=O)C)Br)/s2)C1c4ccccc4)C,16410189,NULL,13001733,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,541.42,8,0,5,3.49,86.96,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0034,,AB00991123,C1CC(=CC2=CC=CC=C21)S(=O)(=O)NC3=CC=C(C=C3)N4C=NN=N4,17483530,NULL,17026724,Replication,Cytotoxicity kit,10-point concentration response assay,"Enamine Ltd. (Kiev, Ukraine)",Vero cells,0,3900,Inhibition of virus-induced cytopathic effect,353.41,6,1,4,2.39,89.77,24735442,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994909/,kanikatuteja@gmail.com
NVIC0035,,Phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1775,NULL,1710,"Non-selective inhibitor of sodium, sodium/hydrogen transporter and calcium channels",HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,51580,0,Sodium channel blockage,252.27,2,2,2,1.77,58.2,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0036,,"(5Z)-5-[[3-(1-benzofuran-2-yl)-1-phenylpyrazol-4-yl]methylidene]-2-[(2R,6R)-2,6-dimethylmor pholin-4-yl]-1,3-thiazol-4-one",CC1CN(CC(O1)C)C2=NC(=O)C(=CC3=CN(N=C3C4=CC5=CC=CC=C5O4)C6=CC=CC=C6)S2,1784648,NULL,1402075,attachment glycoprotein (Niv-G),"virtual screening, molecular docking and ADMET prediction",ADME/Tox filter server,ZINC database,NULL,0,0,Inhibit the NiV-G,484.58,7,0,3,5.37,72.86,NULL,https://www.omicsonline.org/open-access/virtual-screening-for-identification-of-small-lead-compound-inhibitors-ofnipah-virus-attachment-glycoprotein-2153-0645-1000180.pdf,nishisharmacool14@gmail.com
NVIC0037,,5-N-ethyl isopropyl amiloride,CCN(C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N)C(C)C,1795,NULL,1729,Inhibitor of sodium/hydrogen transporter,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,5960,0,Sodium channel blockage,299.77,5,3,4,0.36,136.51,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0038,,5'-Deoxy-5'-(Methylthio)-Tubercidin,CSCC1C(C(C(O1)N2C=CC3=C(N=CN=C32)N)O)O,188350,DB02933,163705,Methylthioadenosine phosphorylase,NULL,NULL,NULL,NULL,0,0,NULL,296.35,8,3,3,0,106.42,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0039,,Adenine,C1=NC2=NC=NC(=C2N1)N,190,DB00173,185,Methylthioadenosine phosphorylase,NULL,NULL,NULL,NULL,0,0,NULL,135.13,4,2,0,-0.06,80.48,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0040,,1926-2281,c1cc(cc2c1cc(/c(=N/c3c(c4c(s3)CCCC4)C(=O)N)/o2)C(=O)N)O,NULL,NULL,21538902,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,383.43,6,3,3,2.51,131.91,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0041,,G1,CC1=CC=C(CN2C(CO)=CN=C2SCC(=O)N2CCCC3=C2C=CC=C3)C=C1,22576158,NULL,20426133,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,407.54,5,1,6,3.8,58.36,33450550,https://pubmed.ncbi.nlm.nih.gov/33450550/,bhupender.thakur855@gmail.com
NVIC0042,,G2,CN1C(=O)N(C)C2=NC(=NC(SCC(=O)NCCC3=CC=CC=C3)=C2C1=O)C1=CC=CO1,22581503,NULL,20433096,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,451.51,9,1,7,1.74,112.02,33450550,https://pubmed.ncbi.nlm.nih.gov/33450550/,bhupender.thakur855@gmail.com
NVIC0043,,G4,C1CC(OC1)CNC(=O)C(=O)NC2=C3CSCC3=NN2C4=CC=C(C=C4)F,22584902,NULL,20439076,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,390.44,6,2,4,1.99,85.25,33450550,https://pubmed.ncbi.nlm.nih.gov/33450550/,bhupender.thakur855@gmail.com
NVIC0044,,FD001,C1=CC=C(C=C1)CCN2C(=O)C(=CC3=CC=C(O3)C4=CC(=C(C=C4)Cl)C(=O)O)SC2=S,2277040,NULL,NULL,class I viral fusion protein,"Cytotoxicity, pseudo virus infection inhibition",Luciferase activity,American Type Culture Collection (ATCC),U87,410,0,inhibition of class I viral fusion protein,469.97,5,1,6,5.74,70.75,35336896,https://pubmed.ncbi.nlm.nih.gov/35336896/,bhupender.thakur855@gmail.com
NVIC0045,,"1-N,4-N-bis(3-phenylphenyl)piperazine-1,4-dicarboxamide",C1CN(CCN1C(=O)NC2=CC=CC(=C2)C3=CC=CC=C3)C(=O)NC4=CC=CC(=C4)C5=CC=CC=C5,235811,NULL,205764,attachment glycoprotein (Niv-G),"virtual screening, molecular docking and ADMET prediction",ADME/Tox filter server,NCI diversity set-II,NULL,0,0,Inhibit the NiV-G,476.58,2,2,4,6.4,64.68,NULL,https://www.omicsonline.org/open-access/virtual-screening-for-identification-of-small-lead-compound-inhibitors-ofnipah-virus-attachment-glycoprotein-2153-0645-1000180.pdf,nishisharmacool14@gmail.com
NVIC0046,,"4-[(1-{[4-(3-chlorophenyl)-1-methyl-2-oxo-1,2-dihydroquinolin-6-yl]methyl}-1H-imidazol-5-yl)(hydroxy)methyl]benzonitrile",CN1C2=C(C=C(C=C2)CN3C=NC=C3C(C4=CC=C(C=C4)C#N)O)C(=CC1=O)C5=CC(=CC=C5)Cl,23646770,NULL,NULL,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of NiV-G chain,480.96,6,1,5,5.06,83.84,37442011,https://pubmed.ncbi.nlm.nih.gov/37442011/,bhupender.thakur855@gmail.com
NVIC0046,,"4-[(1-{[4-(3-chlorophenyl)-1-methyl-2-oxo-1,2-dihydroquinolin-6-yl]methyl}-1H-imidazol-5-yl)(hydroxy)methyl]benzonitrile",CN1C2=C(C=C(C=C2)CN3C=NC=C3C(C4=CC=C(C=C4)C#N)O)C(=CC1=O)C5=CC(=CC=C5)Cl,23646770,NULL,NULL,Ephrin-B2,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Ephrin-B2 chain,480.96,6,1,5,5.06,83.84,37442011,https://pubmed.ncbi.nlm.nih.gov/37442011/,bhupender.thakur855@gmail.com
NVIC0047,,Clemastine,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C.C(=CC(=O)O)C(=O)O,23724780,NULL,58178872,NULL,NULL,NULL,MicroSource Spectrum Collection,NULL,0,0,NULL,459.97,4,2,8,4.82,87.07,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0048,,"BHQ(2,5-di-(t-butyl)-1,4-hydroquinone)",CC(C)(C)C1=CC(=C(C=C1O)C(C)(C)C)O,2374,NULL,2283,Stimulates calcium release from the ER via IP3,HTS immunolabeling assay,Non-linear regression analysis,"Merck Scientific (Kilsyth, VIC Australia)",Vero cells,12210,0,Inhibition of henipavirus replication,222.33,2,2,0,3.69,40.46,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0049,,Iron,[Fe],23925,DB01592,22368,Transferrin receptor protein 1,NULL,NULL,NULL,NULL,0,0,NULL,55.85,0,0,0,0,0,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0050,,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",CC1=CC(=CC=C1)CC2=NN(C3=NC=NC(=C23)N)C(C)(C)C,24865390,DB08699,23976079,Calcium/calmodulin-dependent protein kinase 2 delta,NULL,NULL,NULL,NULL,0,0,NULL,295.39,5,1,2,3.06,69.62,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0051,,Caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,2519,NULL,2424,Release ER calcium stores,HTS immunolabeling assay,Non-linear regression analysis,Streptomyces conglobatus,Vero cells,7562710,0,Inhibition of henipavirus replication,194.19,6,0,0,-1.03,61.82,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0052,,Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,2520,NULL,2425,L/T-type Calcium channel antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,21660,0,Calcium channel blockage,454.61,6,0,13,5.09,63.95,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0053,,AB00993210,CN(C)S(=O)(=O)C1=CC2=C(C=C1)N(CC2)S(=O)(=O)C3=CC=CS3,25672978,NULL,22443136,Replication,Cytotoxicity kit,10-point concentration response assay,"Enamine Ltd. (Kiev, Ukraine)",Vero cells,0,7800,Inhibition of virus-induced cytopathic effect,372.49,5,0,4,1.75,74.76,24735442,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994909/,kanikatuteja@gmail.com
NVIC0054,,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,2719,DB00608,2618,Cathepsin L,Virus titration in vivo,Daily clinical observations,"Sigma Aldrich, NSW, Australia",Ferret model,0,0,Preventing or moderating infection,319.88,3,1,8,4.81,28.16,19759137,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772715/,kanikatuteja@gmail.com
NVIC0054,,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,2719,DB00608,2618,fusion glycoprotein (NiV-F) ,HTS immunolabeling assay,Multicycle replication assay,NULL,Vero cells,2500,0,Reduced the virus titer,319.88,3,1,8,4.81,28.16,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,kanikatuteja@gmail.com
NVIC0054,,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,2719,DB00608,2618,RNA replication,CPE visual,Non-linear regression analysis,Sigma,HeLa cells,620,0,Reduce the spread and infection of NiV,319.88,3,1,8,4.81,28.16,19889926,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888097/,nishisharmacool14@gmail.com
NVIC0055,,Quinacrine dihydrochloride dihydrate,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC.O.O.Cl.Cl,2725002,NULL,2007115,NULL,NULL,NULL,Prestwick,NULL,0,0,NULL,508.92,4,1,9,5.17,100.39,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0056,,PMA(Phorbol 12-myristate 13-acetate),CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C,27924,NULL,25977,Activates PKC mediated pathways,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,372120,0,Inhibition of viral replication,616.84,8,3,15,5.75,130.36,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0057,,Clotrimazole,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,2812,NULL,2710,Release ER calcium stores,HTS immunolabeling assay,Non-linear regression analysis,Streptomyces conglobatus,Vero cells,3470,0,Inhibition of henipavirus replication,344.85,2,0,4,5.38,17.82,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0058,,Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,31703,DB00997,29400,NADH dehydrogenase iron-sulfur protein 2,NULL,NULL,NULL,NULL,0,0,NULL,543.53,12,6,5,0,206.07,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0059,,"4-oxo-1,4-Dihydroquinoline-3,7-dicarboxylic Acid",C1=CC2=C(C=C1C(=O)O)NC=C(C2=O)C(=O)O,328523,NULL,290967,fusion glycoprotein (NiV-F) ,Cell-cell fusion assay,Size of the syncytia,NULL,Vero cells,0,8000,Inhibit NiV-induced virus-cell and cell-cell fusion,233.18,3,3,2,0.92,107.46,19499921,https://pubs.acs.org/doi/full/10.1021/jm900411s,kanikatuteja@gmail.com
NVIC0060,,"9-dioxo-8-azaspiro[4.4]nonan-8-yl)-3-methylphenyl]-2-methylphenyl]-8-azaspiro[4.4]nonane-7,9-dione",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N3C(=O)CC4(C3=O)CCCC4)C)N5C(=O)CC6(C5=O)CCCC6,328761,NULL,291201,attachment glycoprotein (Niv-G),"virtual screening, molecular docking and ADMET prediction",ADME/Tox filter server,NCI diversity set-II,NULL,0,0,Inhibit the NiV-G,484.6,4,0,3,5.62,74.76,NULL,https://www.omicsonline.org/open-access/virtual-screening-for-identification-of-small-lead-compound-inhibitors-ofnipah-virus-attachment-glycoprotein-2153-0645-1000180.pdf,nishisharmacool14@gmail.com
NVIC0061,,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,3446,NULL,3328,Calcium channel antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,538700,0,Calcium channel blockage,171.24,2,2,3,1.37,63.32,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0062,,Gentian Violet,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C,3468,DB00406,3349,Calcium modulation,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,525,0,Inhibition of NiV infection.,372.54,2,0,4,4.46,9.49,19889218,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781006/,kanikatuteja@gmail.com
NVIC0063,,Hypericin,CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O,3663,DB13014,4444511,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,504.45,8,6,0,5.08,155.52,36808582,https://pubmed.ncbi.nlm.nih.gov/36808582/,bhupender.thakur855@gmail.com
NVIC0064,,Iodixanol,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,3724,DB01249,3593,Ephrin-B2,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of attachment glycoprotein (NiV-G),1550.19,15,13,22,-1.59,339.09,38355980,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866979/,bhupender.thakur855@gmail.com
NVIC0064,,Iodixanol,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,3724,DB01249,3593,matrix protein (NiV-M),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of matrix protein (NiV-M),1550.19,15,13,22,-1.59,339.09,38355980,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866979/,bhupender.thakur855@gmail.com
NVIC0065,,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,37542,DB00811,34439,Crossing of the blood-brain barrier,"Clinical trial, non randomized",Follow-up of pateints,NULL,NULL,0,0,Reduction in mortality,244.21,8,4,3,-3.01,143.72,11409437,https://www.ncbi.nlm.nih.gov/pubmed/11409437,kanikatuteja@gmail.com
NVIC0065,,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,37542,DB00811,34439,Replication,HTS immunolabeling assay,HRP-chemiluminescent,NULL,Vero cells,0,3356,Virus inhibition,244.21,8,4,3,-3.01,143.72,18313148,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653211/,kanikatuteja@gmail.com
NVIC0065,,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,37542,DB00811,34439,Replication,HTS immunolabeling assay,Fluorescent immunodetection,NULL,Vero cells,0,6041,Virus inhibition,244.21,8,4,3,-3.01,143.72,18313148,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653211/,priyankapaul008@gmail.com
NVIC0065,,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,37542,DB00811,34439,Replication,CPE visual,NULL,NULL,Vero E6 cells,0,0,Inhibit replication,244.21,8,4,3,-3.01,143.72,16641448,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472238/,kanikatuteja@gmail.com
NVIC0065,,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,37542,DB00811,34439,RNA replication,CPE visual,Non-linear regression analysis,Valeant,HeLa cells,4180,0,Reduce the spread and infection of NiV,244.21,8,4,3,-3.01,143.72,19889926,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888097/,nishisharmacool14@gmail.com
NVIC0066,,Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,387447,DB00188,343402,matrix protein (NiV-M),CPE visual,Virus Titre Reduction assay,ChemieTek,HeLa cells,2.7,0,Inhibition of NiV infection.,384.25,6,4,9,0.36,124.44,21085610,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978725/,kanikatuteja@gmail.com
NVIC0067,,"09167(2,2,2-trifluoro-N-[3-(N-naphthylcarbamoyl)(4,5,6,7-tetrahydrobenzo [beta]thiophen-2-yl)]acetamide)",C1CCC2=C(C1)C(=C(S2)NC(=O)C(F)(F)F)C(=O)NC3=CC=CC4=CC=CC=C43,4293368,NULL,3499535,Replication,Reporter assay,NULL,Vitas-M Laboratory,HEK 293T cells,0,72.3,Ablated NiV-LUC2AM activity,418.44,3,2,3,5.53,58.2,24680955,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100748/,kanikatuteja@gmail.com
NVIC0067,,"09167(2,2,2-trifluoro-N-[3-(N-naphthylcarbamoyl)(4,5,6,7-tetrahydrobenzo [beta]thiophen-2-yl)]acetamide)",C1CCC2=C(C1)C(=C(S2)NC(=O)C(F)(F)F)C(=O)NC3=CC=CC4=CC=CC=C43,4293368,NULL,3499535,Replication,Reporter assay,NULL,Vitas-M Laboratory,HEK 293T cells,0,254,Ablated NiV-GFP2AM avtivity,418.44,3,2,3,5.53,58.2,24680955,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100748/,kanikatuteja@gmail.com
NVIC0067,,"09167(2,2,2-trifluoro-N-[3-(N-naphthylcarbamoyl)(4,5,6,7-tetrahydrobenzo [beta]thiophen-2-yl)]acetamide)",C1CCC2=C(C1)C(=C(S2)NC(=O)C(F)(F)F)C(=O)NC3=CC=CC4=CC=CC=C43,4293368,NULL,3499535,Replication,Reporter assay,NULL,Vitas-M Laboratory,HEK 293T cells,0,28.9,Ablated NiV-MY-99 activity,418.44,3,2,3,5.53,58.2,24680955,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100748/,kanikatuteja@gmail.com
NVIC0068,,NADH,1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O,439153,DB00157,388299,Fatty aldehyde dehydrogenase 2,NULL,NULL,NULL,NULL,0,0,NULL,665.45,18,8,11,-2.69,317.62,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0068,,NADH,1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O,439153,DB00157,388299,NADH dehydrogenase iron-sulfur protein 2,NULL,NULL,NULL,NULL,0,0,NULL,665.45,18,8,11,-2.69,317.62,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0069,,5'-S-methyl-5'-thioadenosine,CSCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O,439176,DB02282,388321,Methylthioadenosine phosphorylase,NULL,NULL,NULL,NULL,0,0,NULL,297.34,9,3,3,-0.61,119.31,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0070,,Bradykinin,C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O,439201,NULL,388341,Stimulates calcium release from the ER via IP3,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,34070,0,Inhibition of henipavirus replication,1060.23,13,12,27,-3.99,418.78,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0071,,Naringenin,C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O,439246,DB03467,388383,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,272.26,5,3,1,2.51,86.99,37180429,https://pubmed.ncbi.nlm.nih.gov/37180429/,bhupender.thakur855@gmail.com
NVIC0072,,Monensin,CCC1(CCC(O1)C2(CCC3(O2)CC(C(C(O3)C(C)C(C(C)C(=O)O)OC)C)O)C)C4C(CC(O4)C5C(CC(C(O5)(CO)O)C)C)C,441145,NULL,389937,Sodium ionophore,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,12240,0,Sodium channel blockage,670.88,10,4,10,4.27,153.37,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0073,,"N-(Cyclopropylmethyl)-1-ethyl-6-fluoro-4-oxo-1,4- N-(4-Chlorobenzyl)-1-ethyl-4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide",CCN1C=C(C(=O)C2=C1C=C(C=C2)C(F)(F)F)C(=O)NCC3=CC=C(C=C3)Cl,44190928,NULL,24618766,fusion glycoprotein (NiV-F) ,Cell-cell fusion assay,Size of the syncytia,NULL,Vero cells,0,8000,Inhibit NiV-induced virus-cell and cell-cell fusion,408.81,3,1,4,4.62,51.1,19499921,https://pubs.acs.org/doi/full/10.1021/jm900411s,kanikatuteja@gmail.com
NVIC0074,,"7-(4-Carbamoylpiperidin-1-yl)-1-cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxamide",C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCC(CC4)C(=O)N)F)C(=O)NCC5=C(C=C(C=C5)Cl)Cl,44191023,NULL,24623404,fusion glycoprotein (NiV-F) ,Cell-cell fusion assay,Size of the syncytia,https://pubchem.ncbi.nlm.nih.gov/bioassay/420714#section=Source,Vero cells,0,1500,Inhibit NiV-induced virus-cell and cell-cell fusion,531.42,5,2,6,4.41,97.43,19499921,https://pubs.acs.org/doi/full/10.1021/jm900411s,anshu@imtech.res.in
NVIC0075,,"Ethyl 1-[3-(2,4-Dichlorobenzylcarbamoyl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-7-yl]piperidine-4-carboxylate",CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCC(CC3)C(=O)OCC)F)C(=O)NCC4=C(C=C(C=C4)Cl)Cl,44191024,NULL,24624033,fusion glycoprotein (NiV-F) ,Cell-cell fusion assay,Size of the syncytia,https://pubchem.ncbi.nlm.nih.gov/bioassay/420714#section=Source,Vero cells,0,3000,Inhibit NiV-induced virus-cell and cell-cell fusion,548.44,6,1,7,5.18,80.64,19499921,https://pubs.acs.org/doi/full/10.1021/jm900411s,anshu@imtech.res.in
NVIC0076,,"Ethyl 4-[3-(2,4-dichlorobenzylcarbamoyl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-7-yl)]piperazine-1-carboxylate",CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C(=O)OCC)F)C(=O)NCC4=C(C=C(C=C4)Cl)Cl,44191025,NULL,24627369,fusion glycoprotein (NiV-F) ,Cell-cell fusion assay,Size of the syncytia,https://pubchem.ncbi.nlm.nih.gov/bioassay/420714#section=Source,Vero cells,0,4000,Inhibit NiV-induced virus-cell and cell-cell fusion,549.43,6,1,6,4.68,83.88,19499921,https://pubs.acs.org/doi/full/10.1021/jm900411s,anshu@imtech.res.in
NVIC0077,,"Ethyl 4-[1-cyclopropyl-3-(2,4-dichlorobenzylcarbamoyl)-6-fluoro-4-oxo-1,4-dihydroquinoline-7-yl)]piperazine-1-carboxylate",CCOC(=O)N1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)NCC4=C(C=C(C=C4)Cl)Cl)C5CC5)F,44191117,NULL,24618777,fusion glycoprotein (NiV-F) ,Cell-cell fusion assay,Size of the syncytia,https://pubchem.ncbi.nlm.nih.gov/bioassay/420714#section=Source,Vero cells,0,3000,Inhibit NiV-induced virus-cell and cell-cell fusion,561.44,6,1,6,4.99,83.88,19499921,https://pubs.acs.org/doi/full/10.1021/jm900411s,anshu@imtech.res.in
NVIC0078,,GS-441524 (Nuc),C1=C2C(=NC=NN2C(=C1)C3(C(C(C(O3)CO)O)O)C#N)N,44468216,DB15686,28499294,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,"GS-441524 (Nuc) were synthesized at Gilead Sciences, Inc.",HeLa and HEK293T/17 cells,0,1500,Inhibition of transcription in NiV (Rec. M-Luc2AM),291.27,9,4,2,-1.86,149.92,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,priyankapaul008@gmail.com
NVIC0078,,GS-441524 (Nuc),C1=C2C(=NC=NN2C(=C1)C3(C(C(C(O3)CO)O)O)C#N)N,44468216,DB15686,28499294,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,"GS-441524 (Nuc) were synthesized at Gilead Sciences, Inc.",HeLa and HEK293T/17 cells,0,2200,Inhibition of transcription in NiV (Rec. M-GFP2AM),291.27,9,4,2,-1.86,149.92,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,priyankapaul008@gmail.com
NVIC0078,,GS-441524 (Nuc),C1=C2C(=NC=NN2C(=C1)C3(C(C(C(O3)CO)O)O)C#N)N,44468216,DB15686,28499294,RNA-dependent RNA polymerase (RdRp),CPE visual,Non-linear regression analysis,"GS-441524 (Nuc) were synthesized at Gilead Sciences, Inc.",HeLa cells,0,490,Inhibition of replication in NiV (M-1999),291.27,9,4,2,-1.86,149.92,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,priyankapaul008@gmail.com
NVIC0078,,GS-441524 (Nuc),C1=C2C(=NC=NN2C(=C1)C3(C(C(C(O3)CO)O)O)C#N)N,44468216,DB15686,28499294,RNA-dependent RNA polymerase (RdRp),CPE visual / cytotoxicity kit,Non-linear regression analysis,"GS-441524 (Nuc) were synthesized at Gilead Sciences, Inc.",HeLa and H358 cells,0,830,Inhibition of replication in NiV (B-2004) or Inhibition of virus-induced CPE,291.27,9,4,2,-1.86,149.92,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,priyankapaul008@gmail.com
NVIC0079,,Oleic Acid,CCCCCCCCC=CCCCCCCCC(=O)O,445639,NULL,393217,Activates PKC mediated pathways,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,1848200,0,Inhibition of viral replication,282.47,1,1,15,6.11,37.3,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0080,,Thapsigargin,CCCCCCCC(=O)OC1C2C(=C(C1OC(=O)C(=CC)C)C)C3C(C(CC2(C)OC(=O)C)OC(=O)CCC)(C(C(=O)O3)(C)O)O,446378,NULL,23258517,Stimulates calcium release from the ER via IP3,HTS immunolabeling assay,Non-linear regression analysis,"Sigma Chemical Company (St. Louis, MO, USA).",Vero cells,50,0,Inhibition of henipavirus replication,650.76,12,2,13,3.93,171.96,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0081,,Formycin,C1=NC2=C(NN=C2C(=N1)N)C3C(C(C(O3)CO)O)O,447199,DB02281,394361,Methylthioadenosine phosphorylase,NULL,NULL,NULL,NULL,0,0,NULL,267.25,8,5,2,-1.91,150.4,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0082,,CER0144654,CC(C(C)(C)C)NC(=O)C(=O)C1=CC=C(C=C1)C2CCCCC2,44762840,NULL,NULL,NULL,NULL,NULL,"Cerep SA, Paris, France",NULL,0,0,NULL,315.46,2,1,4,4.47,46.17,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0083,,Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,4485,NULL,4330,L-type calcium channel antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,245440,0,Calcium channel blockage,346.34,7,1,4,2.18,107.77,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0084,,4-OH-tamoxifen,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,449459,NULL,4447687,Release ER calcium stores,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,7510,0,Inhibition of henipavirus replication,387.52,3,1,8,5.7,32.7,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0085,,EICAR,C#CC1=C(N=CN1C2C(C(C(O2)CO)O)O)C(=O)N,453180,NULL,399153,Replication,CPE visual,NULL,NULL,Vero E6 cells,0,0,Inhibit replication,267.24,7,4,3,-2.43,130.83,16641448,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472238/,kanikatuteja@gmail.com
NVIC0086,,R1479,C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O,457388,NULL,402579,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,"Carbosynth US LLC, San Diego, CA, USA",NCI-H358 cells,0,1120,Inhibition of transcription in NiV-Luc2AM,284.23,9,4,3,-1.93,179.59,28629988,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648002/,anshu@imtech.res.in
NVIC0086,,R1479,C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O,457388,NULL,402579,RNA-dependent RNA polymerase (RdRp),cytotoxicity kit,Non-linear regression analysis,"Carbosynth US LLC, San Diego, CA, USA",NCI-H358 cells,0,2630,Reduction in cell viability,284.23,9,4,3,-1.93,179.59,28629988,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648002/,kanikatuteja@gmail.com
NVIC0086,,R1479,C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O,457388,NULL,402579,RNA-dependent RNA polymerase (RdRp),CPE visual,Non-linear regression analysis,"Carbosynth US LLC, San Diego, CA, USA",HeLa cells,0,13550,Reduction in cell viability,284.23,9,4,3,-1.93,179.59,28629988,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648002/,kanikatuteja@gmail.com
NVIC0086,,R1479,C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O,457388,NULL,402579,RNA-dependent RNA polymerase (RdRp),CPE visual,Visually assayed for CPE,"Carbosynth US LLC, San Diego, CA, USA",NCI-H358 cells,0,1530,Reduction in cell viability,284.23,9,4,3,-1.93,179.59,28629988,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648002/,kanikatuteja@gmail.com
NVIC0086,,R1479,C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O,457388,NULL,402579,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,"Carbosynth US LLC, San Diego, CA, USA",HeLa cells,0,5680,Inhibition of transcription in NiV-Luc2AM,284.23,9,4,3,-1.93,179.59,28629988,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648002/,priyankapaul008@gmail.com
NVIC0086,,R1479,C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O,457388,NULL,402579,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,"Carbosynth US LLC, San Diego, CA, USA",NCI-H358 cells,0,1640,Inhibition of transcription in NiV-GFP2AM,284.23,9,4,3,-1.93,179.59,28629988,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648002/,priyankapaul008@gmail.com
NVIC0086,,R1479,C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O,457388,NULL,402579,RNA-dependent RNA polymerase (RdRp),virus titer reduction,Visually assayed for CPE,"Carbosynth US LLC, San Diego, CA, USA",HeLa cells,0,4000,Replication inhibition in wild type NiV,284.23,9,4,3,-1.93,179.59,28629988,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648002/,priyankapaul008@gmail.com
NVIC0087,,7-octyl-indolactam,CCCCCCCCC1=C2CC(NC(=O)C(N(C3=CC=CC(=C23)N1)C)C(C)C)CO,45934410,NULL,57263232,Activates PKC mediated pathways,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,306820,0,Inhibition of viral replication,413.61,3,3,9,4.56,68.36,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0088,,MG132,CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1,462382,NULL,406728,matrix protein (NiV-M),CPE visual,Virus Titre Reduction assay,Calbiochem,HeLa cells,0.47,0,Reduction in viral titers,475.63,5,3,14,3.59,113.6,21085610,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978725/,kanikatuteja@gmail.com
NVIC0089,,GYY4137[morpholin-4-ium-4-methoxyphenyl(morpholino)phosphinodithioate],COC1=CC=C(C=C1)P(=S)(N2CCOCC2)S,46937262,NULL,26232138,Viral replication and proinflammatory gene expression.,CPE visual,Plaque assay,"Sigma-Aldrich (St. Louis, MO, USA)",SAE cells,0,0,Replication and inflammatory chemokine production induced by Nipah virus (NiV-B) was inhibited,289.36,3,1,3,1.89,21.7,25740991,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442521/,nishisharmacool14@gmail.com
NVIC0090,,Phenoxybenzamine,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,4768,NULL,4604,Calmoudulin inhibitor,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,6860,0,Inhibition of viral replication,303.83,2,0,8,4.19,12.47,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0091,,Praziquantel,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,4891,NULL,4722,L-type calcium channel antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,33510,0,Calcium channel blockage,312.41,2,0,1,2.53,40.62,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0092,,Favipiravir,C1=C(N=C(C(=O)N1)C(=O)N)F,492405,DB12466,431002,RNA-dependent RNA polymerase (RdRp),cytotoxicity kit,Plaque assay,"Toyama Chemical Company, Ltd. (Toyama, Japan)",Vero CCL81 cells,0,44240,Reduction of viral titres in a dose-dependent manner for NiV-Malaysia (NiV-M),157.1,3,2,1,-0.99,88.84,29765101,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954062/,anshu@imtech.res.in
NVIC0092,,Favipiravir,C1=C(N=C(C(=O)N1)C(=O)N)F,492405,DB12466,431002,RNA-dependent RNA polymerase (RdRp),cytotoxicity kit,Plaque assay,"Toyama Chemical Company, Ltd. (Toyama, Japan)",Vero CCL81 cells,0,14820,Reduction of viral titres in a dose-dependent manner for NiV-Bangladesh (NiV-B),157.1,3,2,1,-0.99,88.84,29765101,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954062/,anshu@imtech.res.in
NVIC0092,,Favipiravir,C1=C(N=C(C(=O)N1)C(=O)N)F,492405,DB12466,431002,RNA-dependent RNA polymerase (RdRp),cytotoxicity kit,Plaque assay,"Toyama Chemical Company, Ltd. (Toyama, Japan)",Vero CCL81 cells,0,14570,Reduction of viral titres in a dose-dependent manner for recombinant NiV expressing Gaussia luciferase and eGFP (rNiV-Gluc-eGFP),157.1,3,2,1,-0.99,88.84,29765101,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954062/,anshu@imtech.res.in
NVIC0093,,Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,4946,NULL,4777,Release ER calcium stores,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,3830,0,Inhibition of henipavirus replication,259.35,3,2,6,2.58,41.49,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0094,,"5-(1,3-Benzodioxol-5-yl)-2-[(3-fluorobenzyl)sulfanyl]-5,8-dihydropyrido[2,3-d]pyrimidine-4,7(1H,6H)-dione",FC1=CC=CC(CSC2=NC(=O)C3=C(NC(=O)CC3C3=CC4=C(OCO4)C=C3)N2)=C1,NULL,NULL,NULL,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,425.44,6,2,4,3.4,93.31,36036362,https://pubmed.ncbi.nlm.nih.gov/36036362/,bhupender.thakur855@gmail.com
NVIC0095,,RSV604,C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)NC4=CC=CC=C4F,5279172,NULL,4442963,RNA-dependent RNA polymerase (RdRp),NULL,NULL,NULL,NULL,0,0,NULL,388.4,3,3,3,3.76,82.59,26029193,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428208/,nishisharmacool14@gmail.com
NVIC0095,,RSV604,C1=CC=C(C=C1)C2=N[C@@H](C(=O)NC3=CC=CC=C32)NC(=O)NC4=CC=CC=C4F,5279172,DB15197,4442963,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of NiV attachment glycoprotein G,388.4,3,3,3,3.76,82.59,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com
NVIC0095,,RSV604,C1=CC=C(C=C1)C2=N[C@@H](C(=O)NC3=CC=CC=C32)NC(=O)NC4=CC=CC=C4F,5279172,DB15197,4442963,nucleoprotein,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of nucleoprotein,388.4,3,3,3,3.76,82.59,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com
NVIC0096,,Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,5280754,NULL,4447449,SERCA,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,12640,0,Removal of cytosolic calcium,1202.64,12,5,15,3.27,278.8,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0097,,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,5280795,NULL,4444353,Release ER calcium stores,HTS immunolabeling assay,Non-linear regression analysis,Streptomyces conglobatus,Vero cells,55630,0,Inhibition of henipavirus replication,384.65,1,1,6,7.62,20.23,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0098,,Rutin,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C3=CC(O)=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,5280805,DB01698,4444362,matrix protein (NiV-M),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of matrix protein (NiV-M),610.52,16,10,6,-1.69,269.43,38355980,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866979/,bhupender.thakur855@gmail.com
NVIC0099,,Rottlerin,CC1=C(C(=C(C(=C1O)C(=O)C)O)CC2=C(C3=C(C(=C2O)C(=O)C=CC4=CC=CC=C4)OC(C=C3)(C)C)O)O,5281847,NULL,4445144,Inhibits PKC mediated pathways,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,19820,0,Inhibition of viral replication,516.55,8,5,6,5.4,144.52,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0100,,25-hydroxy-cholecalciferol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,5283731,NULL,4446820,Release ER calcium stores,HTS immunolabeling assay,Non-linear regression analysis,"Sigma Chemical Company (St. Louis, MO, USA).",Vero cells,30860,0,Inhibition of henipavirus replication,400.65,2,2,6,6.73,40.46,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0101,,Xestospongin C,C1CCCC2CCN3CCCC(C3O2)CCCCCCC4CCN5CCCC(C5O4)CC1,5311502,NULL,4470979,Inhibitor of IP3 mediated calcium release from the ER,HTS immunolabeling assay,Non-linear regression analysis,"Merck Scientific (Kilsyth, VIC Australia)",Vero cells,7010,0,Inhibition of henipavirus replication,446.72,4,0,0,6.34,24.94,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0102,,Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,5328940,DB06616,4486102,Calcium/calmodulin-dependent protein kinase 2 delta,NULL,NULL,NULL,NULL,0,0,NULL,530.46,8,1,9,5.19,82.88,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0103,,Serpentinine,CC=C1CN2CCC3=C(C2CC1C(CC4=C[N+]5=C(CC6C(C5)C(OC=C6C(=O)OC)C)C7=C4C8=CC=CC=C8N7)C(=O)OC)NC9=CC=CC=C39,5351576,NULL,28424374,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,685.85,6,2,5,6.25,100.53,36473711,https://pubmed.ncbi.nlm.nih.gov/36473711/,bhupender.thakur855@gmail.com
NVIC0104,,Isoniazid Pyruvate,CC(=NNC(=O)C1=CC=NC=C1)C(=O)O,5359563,NULL,4514321,Ephrin-B3,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Ephrin-B3,207.19,4,2,3,0.27,91.65,36808582,https://pubmed.ncbi.nlm.nih.gov/36808582/,bhupender.thakur855@gmail.com
NVIC0105,,Manninotriose,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O,5461026,NULL,4574400,Non-Structural Protein - C,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Non-Structural Protein - C,504.44,16,11,11,-7.73,276.52,37222609,https://pubmed.ncbi.nlm.nih.gov/37222609/,bhupender.thakur855@gmail.com
NVIC0106,,GS-441524,C1=C2C(=NC=NN2C(=C1)C3(C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)C#N)N,56832906,NULL,28499861,RNA-dependent RNA polymerase (RdRp),Reporter assay,Non-linear regression analysis,NULL,HeLa and HEK293T/17 cells,0,490,Inhibition of transcription in NiV (Rec. M-Luc2AM),531.2,14,7,8,-1.51,289.51,28262699,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338263/,anshu@imtech.res.in
NVIC0107,,3229-0947,O=C(Nc1ccc(cc1)/C(=N/Nc2nc(nc(n2)Nc3ccccc3)N4CCOCC4)C)C,5759988,NULL,7867644,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,446.52,9,3,7,3.25,116.66,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0108,,Pemirolast,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,57697,DB00885,51990,Ephrin-B2,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Ephrin-B2,228.22,6,1,1,0.18,88.83,36808582,https://pubmed.ncbi.nlm.nih.gov/36808582/,bhupender.thakur855@gmail.com
NVIC0109,,Triphosphopyridine nucleotide,C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)C(=O)N,5885,DB03461,5674,Non-Structural Protein - C,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Non-Structural Protein - C,743.41,19,8,13,-3.53,367.62,37222609,https://pubmed.ncbi.nlm.nih.gov/37222609/,bhupender.thakur855@gmail.com
NVIC0110,,6-Azauridine,C1=NN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,5901,NULL,203593,Replication,CPE visual,NULL,NULL,Vero E6 cells,0,0,Inhibit replication,245.19,8,4,2,-3.46,137.67,16641448,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472238/,kanikatuteja@gmail.com
NVIC0111,,Amlodipine besylate,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O,60496,NULL,54537,L-type calcium channel antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,643530,0,Calcium channel blockage,567.06,9,3,9,3.2,154.25,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0112,,Mibefradil,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,60663,NULL,54673,T-type calcium channels antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,6110,0,Calcium channel blockage,495.64,5,1,11,5.27,67.45,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0113,,Gallium nitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Ga+3],61635,DB05260,55543,Transferrin receptor protein 1,NULL,NULL,NULL,NULL,0,0,NULL,255.74,9,0,0,-1.1,198.6,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0114,,Gliotoxin,CN1C(=O)C23CC4=CC=CC(C4N2C(=O)C1(SS3)CO)O,6223,NULL,5988,Calcium modulation,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,740,0,Inhibition of NiV infection.,326.4,6,2,1,-0.3,81.08,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0114,,Gliotoxin,CN1C(=O)C23CC4=CC=CC(C4N2C(=O)C1(SS3)CO)O,6223,NULL,5988,Calcium modulation,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,149,0,Inhibition of NiV infection.,326.4,6,2,1,-0.3,81.08,19889218,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781006/,kanikatuteja@gmail.com
NVIC0115,,Arg-vasopressin,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,644077,NULL,559126,Stimulates calcium release from the ER via IP3,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,35270,0,Inhibition of henipavirus replication,1084.25,16,14,19,-5.4,463.93,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0116,,Lanthanum Chloride,Cl[La](Cl)Cl,64735,NULL,58275,Calcium channel antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,1030790,0,Calcium channel blockage,245.27,0,0,0,2.07,0,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0117,,CHLOROQUINE DIPHOSPHATE,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,64927,NULL,58455,NULL,NULL,NULL,MP Biomedicals,NULL,0,0,NULL,515.87,5,7,8,2.95,183.68,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0118,,25-hydroxycholesterol,CC(CCCC(C)(C)O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,65094,DB04705,58604,Replication,Plaque assay,Virus Titre Reduction assay,Produced within mammalian species,HeLa cells,1000,0,Inhibition of replication,402.66,2,2,5,6.5,40.46,23273844,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698975/,kanikatuteja@gmail.com
NVIC0119,,Gallium citrate Ga-67,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ga+3],65430,DB06784,58893,Transferrin receptor protein 1,NULL,NULL,NULL,NULL,0,0,NULL,256.03,7,1,5,-5.63,140.62,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0120,,"5,7-dichloro-4-hydroxy-3-[3-(pyrimidin-5-yl)propylthio)-2-(1H)-quinolone",C1=C(C=C(C2=C1NC(=O)C(=C2O)SCCCC3=CN=CN=C3)Cl)Cl,67726448,NULL,NULL,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of NiV-G chain,382.27,5,2,5,4.06,78.87,37442011,https://pubmed.ncbi.nlm.nih.gov/37442011/,bhupender.thakur855@gmail.com
NVIC0120,,"5,7-dichloro-4-hydroxy-3-[3-(pyrimidin-5-yl)propylthio)-2-(1H)-quinolone",C1=C(C=C(C2=C1NC(=O)C(=C2O)SCCCC3=CN=CN=C3)Cl)Cl,67726448,NULL,NULL,Ephrin-B2,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Ephrin-B2 chain,382.27,5,2,5,4.06,78.87,37442011,https://pubmed.ncbi.nlm.nih.gov/37442011/,bhupender.thakur855@gmail.com
NVIC0121,,Ionomycin,CC(CCC(=O)O)CC(C)CC(C)C(=O)C=C(C(C)CC(C)CC=CC(C)C(C(C)C(CC1CCC(O1)(C)C2CCC(O2)(C)C(C)O)O)O)O,6912226,NULL,5288579,Calcium ionophore,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,5190,0,Inhibition of henipavirus replication,709.02,8,5,22,7.8,153.75,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0122,,Dantrolene,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],6914273,NULL,5036403,Inhibitor of ryanodine receptor mediated calcium release from the ER,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,12410,0,Inhibition of henipavirus replication,314.26,6,1,4,1.74,118.05,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0123,,Tetrandine,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC,73078,NULL,65868,L/T-type Calcium channel antagonist,HTS immunolabeling assay,Non-linear regression analysis,NULL,Vero cells,654800,0,Calcium channel blockage,622.76,8,0,4,7.16,61.86,20668647,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910441/,kanikatuteja@gmail.com
NVIC0124,,0848-0115,C=CCC1=CC=CC2=C1OC(=O)C(=C2)C(=O)NC3=CC=CC=C3C(=O)O,753815,NULL,659227,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,349.34,4,2,5,3.47,96.61,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0125,,"7402683 (methyl-N-[4-(tert-butylamino)-6-(ethylamino)-1,3,5-triazin-2-yl]-N-cyanoglycinate)",CCNC1=NC(=NC(=N1)N(CC(=O)OC)C#N)NC(C)(C)C,755369,NULL,660664,fusion glycoprotein (NiV-F) ,Reporter assay,Pseudovirus inhibition assay,"Chembridge Corporation (San Diego, CA)",293FT cells,0,0,Inhibited the entry of NiV-F0 virus,307.36,9,2,6,0.97,116.06,24501399,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993759/,nishisharmacool14@gmail.com
NVIC0126,,"7,7-Dimethyl-1-(4-methylphenyl)-3-(4-morpholinylcarbonyl)-7,8-dihydro-2,5(1H,6H)-quinolinedione",CC1=CC=C(C=C1)N1C(=O)C(=CC2=C1CC(C)(C)CC2=O)C(=O)N1CCOCC1,NULL,NULL,NULL,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,394.47,5,0,2,2.77,68.61,36036362,https://pubmed.ncbi.nlm.nih.gov/36036362/,bhupender.thakur855@gmail.com
NVIC0127,,1013-0406,n1c(nc(nc1N2CCOCC2)N/N=C/c3cccnc3)Nc4ccccc4,NULL,NULL,7917123,NULL,NULL,NULL,"ChemDiv (San Diego, CA)",NULL,0,0,NULL,376.42,9,2,6,2.29,100.45,19264786,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682105/,nishisharmacool14@gmail.com
NVIC0128,,AB00992391,C1=CC(=CC=C1NS(=O)(=O)C2=CC(=C(C=C2)F)F)N3C=NN=N3,8189728,NULL,6491411,Replication,Cytotoxicity kit,10-point concentration response assay,"Enamine Ltd. (Kiev, Ukraine)",Vero cells,0,11700,Inhibition of virus-induced cytopathic effect,337.31,6,1,4,1.74,89.77,24735442,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994909/,kanikatuteja@gmail.com
NVIC0129,,"5705213 {methyl-N-[4,6-bis(isopropylamino)-1,3,5-triazin-2-yl]-N-cyanoglycinate}",CC(C)NC1=NC(=NC(=N1)N(CC(=O)OC)C#N)NC(C)C,826236,NULL,721677,fusion glycoprotein (NiV-F) ,Reporter assay,Pseudovirus inhibition assay,"Chembridge Corporation (San Diego, CA)",293FT cells,0,0,Inhibited the entry of NiV-F0 virus,307.36,9,2,7,0.97,116.06,24501399,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993759/,nishisharmacool14@gmail.com
NVIC0130,,3-Indolebutyric Acid,C1=CC=C2C(=C1)C(=CN2)CCCC(=O)O,8617,DB02740,8298,Major histocompatibility complex class I-c,NULL,NULL,NULL,NULL,0,0,NULL,203.24,1,2,4,2.58,53.09,28904190,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686741/,kanikatuteja@gmail.com
NVIC0131,,"4-oxo-1,4-Dihydroquinoline-3,5-dicarboxylic Acid",C1=CC(=C2C(=C1)NC=C(C2=O)C(=O)O)C(=O)O,91619677,NULL,62941102,fusion glycoprotein (NiV-F) ,Cell-cell fusion assay,Size of the syncytia,NULL,Vero cells,0,8000,Inhibit NiV-induced virus-cell and cell-cell fusion,233.18,3,3,2,0.92,107.46,19499921,https://pubs.acs.org/doi/full/10.1021/jm900411s,kanikatuteja@gmail.com
NVIC0132,,G5,CC1=CC=C(NC(=O)N[C@@H](C(=O)N2CCC3=C2C=CC=C3)C2=CC=CC=C2)C=C1,92881596,NULL,23022263,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of glycoprotein,385.47,2,2,4,4.45,61.44,33450550,https://pubmed.ncbi.nlm.nih.gov/33450550/,bhupender.thakur855@gmail.com
NVIC0133,,fagopyritol B3,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC3C(C(C(C(O3)OC4C(C(C(C(C4O)O)O)O)O)O)O)O)O)O)O)O)O)O)O,9896047,NULL,30777084,Non-Structural Protein - C,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of Non-Structural Protein - C,666.58,21,15,9,-10.36,358.83,37222609,https://pubmed.ncbi.nlm.nih.gov/37222609/,bhupender.thakur855@gmail.com
NVIC0134,,C1,CCOC1=CC=C(C=C1)C1N(CCC2=C1NC1C=CC=CC21)C(=O)C1CCC1,NULL,NULL,NULL,NULL,HTS Assay,Virus Titre Reduction assay,"ChemDiv (San Diego, CA)","HEK 293T, BSR-T7/5, Vero E6, Vero 76",1830,0,inhibited the replication,358.49,1,1,3,5,36.1,34077807,https://pubmed.ncbi.nlm.nih.gov/34077807/,bhupender.thakur855@gmail.com
NVIC0135,,CARS0358,[H][C@]12N(CC3=CC=CC=C3)CC[C@@]11C(NC3=C1C=CC=C3)=C(CC2([H])C[C@@]1(CC)COC(C)(C)O1)C(=O)OC,NULL,NULL,NULL,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of NiV attachment glycoprotein G,502.66,6,2,6,5.15,68.82,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com
NVIC0135,,CARS0358,[H][C@]12N(CC3=CC=CC=C3)CC[C@@]11C(NC3=C1C=CC=C3)=C(CC2([H])C[C@@]1(CC)COC(C)(C)O1)C(=O)OC,NULL,NULL,NULL,fusion glycoprotein (NiV-F) ,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of fusion glycoprotein,502.66,6,2,6,5.15,68.82,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com
NVIC0135,,CARS0358,[H][C@]12N(CC3=CC=CC=C3)CC[C@@]11C(NC3=C1C=CC=C3)=C(CC2([H])C[C@@]1(CC)COC(C)(C)O1)C(=O)OC,NULL,NULL,NULL,nucleoprotein,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of nucleoprotein,502.66,6,2,6,5.15,68.82,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com
NVIC0136,,F1,CC1=CC=C(C=C1)C1=CSC(NC(=O)CS(=O)(=O)C2=CC=C(C)C=C2)=N1,NULL,NULL,NULL,NULL,HTS Assay,Virus Titre Reduction assay,"ChemDiv (San Diego, CA)",Vero 76,4150,0,inhibited the replication,390.49,6,3,5,2.21,95.5,34077807,https://pubmed.ncbi.nlm.nih.gov/34077807/,bhupender.thakur855@gmail.com
NVIC0137,,F10,OC1=NC=C(F)N=C1CN1CCN(CC1)C1=NN=C(O1)C1=CC=CC=C1,NULL,NULL,NULL,attachment glycoprotein (Niv-G),"DFT, Molecular docking and ADMET",NULL,NULL,NULL,0,0,inhibition of glycoprotein,370.34,8,1,3,1.33,108.48,33458565,https://pubmed.ncbi.nlm.nih.gov/33458565/,bhupender.thakur855@gmail.com
NVIC0138,,F11,OC1=NC=C(F)N=C1CN1CCN(CC1)C1=NN=C(O1)C1=CC=C(Cl)C=C1,NULL,NULL,NULL,attachment glycoprotein (Niv-G),"DFT, Molecular docking and ADMET",NULL,NULL,NULL,0,0,inhibition of glycoprotein,404.79,8,1,3,1.99,108.48,33458565,https://pubmed.ncbi.nlm.nih.gov/33458565/,bhupender.thakur855@gmail.com
NVIC0139,,F12,OC1=CC=C(C=C1)C1=NN=C(O1)N1CCN(CC1)C(=O)C1=NC(F)=CN=C1O,NULL,NULL,NULL,attachment glycoprotein (Niv-G),"DFT, Molecular docking and ADMET",NULL,NULL,NULL,0,0,inhibition of glycoprotein,386.34,9,2,3,1.04,128.71,33458565,https://pubmed.ncbi.nlm.nih.gov/33458565/,bhupender.thakur855@gmail.com
NVIC0140,,Iotrolan,CN(C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I,3738,DB09487,3607,Ephrin-B2,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of attachment glycoprotein (NiV-G),1626.24,18,16,24,-3.89,399.78,38355980,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866979/,bhupender.thakur855@gmail.com
NVIC0140,,Iotrolan,CN(C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I,3738,DB09487,3607,matrix protein (NiV-M),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of matrix protein (NiV-M),1626.24,18,16,24,-3.89,399.78,38355980,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866979/,bhupender.thakur855@gmail.com
NVIC0141,,Norov-29,NC1=NC=NN2C=CC=C12.[H][C@@]1(C)O[C@]([H])(COP(O)(O)=O)[C@@H](O)[C@H]1O,NULL,NULL,NULL,RNA-dependent RNA polymerase (RdRp),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of RNA-dependent RNA polymerase (RdRp),346.24,9,5,4,-1.42,172.66,36205638,https://pubmed.ncbi.nlm.nih.gov/36205638/,bhupender.thakur855@gmail.com
NVIC0142,,RASE0125 (17-O-Acetyl-nortetraphyllicine),C(C)(=O)OC1C2[C@H]3N4C/C(/C2CC4[C@@H]4NC=2C=CC=CC2[C@]41C3)=C/C,NULL,NULL,NULL,attachment glycoprotein (Niv-G),molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of NiV attachment glycoprotein G,352.48,4,2,1,3.24,50.36,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com
NVIC0142,,RASE0125 (17-O-Acetyl-nortetraphyllicine),C(C)(=O)OC1C2[C@H]3N4C/C(/C2CC4[C@@H]4NC=2C=CC=CC2[C@]41C3)=C/C,NULL,NULL,NULL,fusion glycoprotein (NiV-F) ,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of fusion glycoprotein,352.48,4,2,1,3.24,50.36,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com
NVIC0142,,RASE0125 (17-O-Acetyl-nortetraphyllicine),C(C)(=O)OC1C2[C@H]3N4C/C(/C2CC4[C@@H]4NC=2C=CC=CC2[C@]41C3)=C/C,NULL,NULL,NULL,nucleoprotein,molecular docking and simulation,NULL,NULL,NULL,0,0,inhibition of nucleoprotein,352.48,4,2,1,3.24,50.36,35744699,https://pubmed.ncbi.nlm.nih.gov/35744699/,bhupender.thakur855@gmail.com